The role of hydrophobic side chains as determinants of antibacterial activity of semisynthetic glycopeptide antibiotics.
暂无分享,去创建一个
L. | Deborah | J N Hobbs | N E Allen | D L LeTourneau | N. Allen | D. L. LeTourneau | J. N. Hobbs | E. | Allen | Norris | LeTourneau | Joe | N. Hobbs
[1] F. Parenti,et al. Teichomycins, new antibiotics from Actinoplanes teichomyceticus Nov. Sp. I. Description of the producer strain, fermentation studies and biological properties. , 1978, The Journal of antibiotics.
[2] Dudley H. Williams,et al. Glycopeptide antibiotic activity and the possible role of dimerization : A model for biological signaling , 1994 .
[3] K. Rolston,et al. In vitro activity of LY264826, a new glycopeptide antibiotic, against gram-positive bacteria isolated from patients with cancer , 1990, Antimicrobial Agents and Chemotherapy.
[4] C. Walsh,et al. Molecular basis for vancomycin resistance in Enterococcus faecium BM4147: biosynthesis of a depsipeptide peptidoglycan precursor by vancomycin resistance proteins VanH and VanA. , 1991, Biochemistry.
[5] G. Whitesides,et al. Affinity capillary electrophoresis can simultaneously measure binding constants of multiple peptides to vancomycin , 1992 .
[6] S. Handwerger,et al. Binding studies of vancomycin to the cytoplasmic peptidoglycan precursors by affinity capillary electrophoresis. , 1994, Analytical chemistry.
[7] S. Handwerger,et al. The cytoplasmic peptidoglycan precursor of vancomycin-resistant Enterococcus faecalis terminates in lactate , 1992, Journal of bacteriology.
[8] T. F. Butler,et al. Reductive alkylation of glycopeptide antibiotics: synthesis and antibacterial activity. , 1996, The Journal of antibiotics.
[9] Dudley H. Williams,et al. Dimerization and membrane anchors in extracellular targeting of vancomycin group antibiotics , 1995, Antimicrobial agents and chemotherapy.
[10] P. Reynolds,et al. Modified peptidoglycan precursors produced by glycopeptide-resistant enterococci. , 1992, FEMS microbiology letters.
[11] N. Allen,et al. Use of capillary electrophoresis to measure dimerization of glycopeptide antibiotics. , 1997, Analytical biochemistry.
[12] H. Perkins,et al. Physicochemical properties of vancomycin and iodovancomycin and their complexes with diacetyl-L-lysyl-D-alanyl-D-alanine. , 1971, The Biochemical journal.
[13] J. Richardson,et al. Biosynthesis of modified peptidoglycan precursors by vancomycin-resistant Enterococcus faecium. , 1992, FEMS microbiology letters.
[14] G. Whitesides,et al. Determination of binding constants of ligands to proteins by affinity capillary electrophoresis: compensation for electroosmotic flow. , 1994, Analytical chemistry.
[15] W. Konings,et al. New Procedure for the Isolation of Membrane Vesicles of Bacillus subtilis and an Electron Microscopy Study of Their Ultrastructure , 1973, Journal of bacteriology.
[16] D. Williams,et al. The structure and mode of action of glycopeptide antibiotics of the vancomycin group. , 1984, Annual review of microbiology.
[17] N. Allen,et al. Molecular interactions of a semisynthetic glycopeptide antibiotic with D-alanyl-D-alanine and D-alanyl-D-lactate residues , 1997, Antimicrobial agents and chemotherapy.
[18] Dudley H. Williams,et al. Cooperativity in ligand binding expressed at a model cell membrane by the vancomycin group antibiotics , 1996 .
[19] R. Jones,et al. In vitro activity and spectrum of LY333328, a novel glycopeptide derivative , 1997, Antimicrobial agents and chemotherapy.
[20] T. Nicas,et al. Characterization of vancomycin resistance in Enterococcus faecium and Enterococcus faecalis , 1989, Antimicrobial Agents and Chemotherapy.
[21] V. Good,et al. MM 45289, a potent glycopeptide antibiotic which interacts weakly with diacetyl-L-lysyl-D-alanyl-D-alanine. , 1990, The Journal of antibiotics.
[22] Dudley H. Williams,et al. Aspects of molecular recognition: solvent exclusion and dimerization of the antibiotic ristocetin when bound to a model bacterial cell-wall precursor , 1989 .
[23] T. Nicas,et al. Inhibition of peptidoglycan biosynthesis in vancomycin-susceptible and -resistant bacteria by a semisynthetic glycopeptide antibiotic , 1996, Antimicrobial agents and chemotherapy.
[24] H. Perkins,et al. THE CHEMICAL BASIS FOR THE ACTION OF THE VANCOMYCIN GROUP OF ANTIBIOTICS , 1974, Annals of the New York Academy of Sciences.
[25] D. M. Berry,et al. Conversion of antibiotic A82846B to orienticin A and structural relationships of related antibiotics , 1989 .
[26] U. Gerhard,et al. Two conformers of the glycopeptide antibiotic teicoplanin with distinct ligand binding sites. , 1995, The Journal of antibiotics.
[27] Dudley H. Williams,et al. The role of the sugar and chlorine substituents in the dimerization of vancomycin antibiotics , 1993 .
[28] R. Nagarajan. Structure-activity relationships of vancomycin-type glycopeptide antibiotics. , 1993, The Journal of antibiotics.
[29] Joel P. Mackay,et al. Dissection of the contributions toward dimerization of glycopeptide antibiotics , 1994 .
[30] J. Mackay,et al. The structure of an asymmetric dimer relevant to the mode of action of the glycopeptide antibiotics. , 1994, Structure.
[31] W. Jencks,et al. On the attribution and additivity of binding energies. , 1981, Proceedings of the National Academy of Sciences of the United States of America.
[32] T. Nicas,et al. Activities of the semisynthetic glycopeptide LY191145 against vancomycin-resistant enterococci and other gram-positive bacteria , 1995, Antimicrobial agents and chemotherapy.
[33] R. Thompson,et al. Semisynthetic glycopeptide antibiotics derived from LY264826 active against vancomycin-resistant enterococci , 1996, Antimicrobial agents and chemotherapy.
[34] G. Rivas,et al. Dimerization of A82846B, vancomycin and ristocetin: influence on antibiotic complexation with cell wall model peptides. , 1996, The Journal of antibiotics.